Benitec Biopharma
BNTC
BNTC
17 hedge funds and large institutions have $5.57M invested in Benitec Biopharma in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 5 closing their positions.
Holders
17
Holders Change
-4
Holders Change %
-19.05%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
![]()
1
RhumbLine Advisers
Boston,
Massachusetts
|
$752 |
2 |
2
Wells Fargo
San Francisco,
California
|
$48 |
Top Sellers
1 |
1
Renaissance Technologies
New York
|
$0 |
2 |
2
Walleye Capital
New York
|
$0 |
3 |
VF
3
Virtu Financial
New York
|
$13K |
4 |
4
Two Sigma Investments
New York
|
$0 |
5 |
CF
5
Cantor Fitzgerald
New York
|
$0 |